Proponents of drug price regulation argue that drug makers raise prices to benefit the value of their stock and invest little of their profits in the development and research of new drugs. Opponents of regulation argue that consumers rely on drug companies to develop new drugs and limiting prices will prevent new lifesaving drugs from being developed. Brazil is ranked top of the pharmaceutical markets in Latin America and third in North America, with a market value of $25.60bn in 2011.
Statistics are shown for this demographic
Response rates from 749 Maceió (capital) voters.
77% Yes |
23% No |
68% Yes |
16% No |
4% Yes, and we should socialize medicine and healthcare |
3% No, limiting drug prices would also limit the investment in research and development into new life-saving drugs |
4% Yes, and the government should regulate the price of all prescription drugs |
2% No, but shorten the lifespan of drug patents |
2% No, and the government should never regulate prices of private businesses |
Trend of support over time for each answer from 749 Maceió (capital) voters.
Loading data...
Loading chart...
Trend of how important this issue is for 749 Maceió (capital) voters.
Loading data...
Loading chart...
Unique answers from Maceió (capital) voters whose views went beyond the provided options.
@99YHSG42yrs2Y
Donald trump an drug use pan is different of going formed as government is not yet over
